Metraipolis › archive › dc_386db70cacfb

Similarity assessment of disulfide isoform profiles between the romosozumab biosimilar and the reference medicinal product — Europe PMC PMID:42098243

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42098243
DOI
10.1038/s41598-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-02T14:21:48.290Z
SHA-256 of the archived text
8e242ed66b1174e8a3871bca173f7ecde0b6c2ba62450ade31d0be9135268e1d
Stable URL of this page
https://metraipolis.com/documento/dc_386db70cacfb

How to cite

Similarity assessment of disulfide isoform profiles between the romosozumab biosimilar and the reference medicinal product — Europe PMC PMID:42098243 — Europe PMC (en), https://europepmc.org/article/MED/42098243 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_386db70cacfb (Metraipolis archive dc_386db70cacfb, sha256 8e242ed66b1174e8a3871bca173f7ecde0b6c2ba62450ade31d0be9135268e1d)
BibTeX
@misc{dc386db70cacfb,
  title = {Similarity assessment of disulfide isoform profiles between the romosozumab biosimilar and the reference medicinal product — Europe PMC PMID:42098243},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42098243},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_386db70cacfb; sha256 8e242ed66b1174e8a3871bca173f7ecde0b6c2ba62450ade31d0be9135268e1d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42098243. Agents can read the archived copy with the MCP tool read_document.